Parkinson病 (JP Patent Analysis Report)
The Technical Field "Parkinson病" had 182 patent application filings in the most recent period (2023-01-01 to 2023-04-30). This is a significantly decreased of -489 filings (-72.9%) over 671 they had in the same period of the previous year (2022-01-01 to 2022-04-30). This report also includes technical terms related to " Parkinson氏病 ", " Parkinson症 ", " パーキンソン氏病 ", " パーキンソン病 ", " パーキンソン症 ", " パ氏病 ", " 振せん麻ひ ", " 振せん麻痺 ", " 振戦麻ひ ", " 振戦麻痺 ", " PD " in the search set.
The highest number of filings in 2019 with 2,758 cases, and their lowest number in 2023 with 347 cases.
The mean of the number of filings over the last 5 years (2019 to 2024, 9,601 cases in total) is 1,600, and the median is 2,072. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,600 patents |
| Std Dev | 1,015 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 347 cases | -82.9 % |
| 2022 year | 2,031 cases | -3.88 % |
| 2021 year | 2,113 cases | -7.53 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for Parkinson病 for the period of the last 10 years (2015-01-01 to 2024-12-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of Parkinson病, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
- Table of Contents
- Foreign Patent Analysis Report
- Patent Filing Summary for Parkinson病
- Search Set (Search Formula/Analysis Patents)
- Related Patent Analysis Report
- Competitors Information
- Top company Information
- • Information on Important Patents
- Provision of patent information to the media
- About this Site
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
Parkinson病, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of Parkinson病 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 19,596 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
Parkinson病
Related Patent Analysis Report
A patent aanlysis report on the following synonyms was found in the technical term "Parkinson病".
- Parkinson病 (Main page / Including the following synonyms)
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as Parkinson病 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, トヨタ自動車株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 11 cases, followed by 株式会社東芝 with 10 cases.
| Name | Cases |
|---|---|
| トヨタ自動車株式会社 | 11 cases |
| 株式会社東芝 | 10 cases |
| キヤノン株式会社 | 9 cases |
| TDK株式会社 | 6 cases |
| 株式会社デンソー | 6 cases |
| セイコーエプソン株式会社 | 4 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Comparing the number of applications of each company, キヤノン株式会社 has the highest number of joint applications in the last for the target period (2015 to 2025) with 146 cases, followed by 株式会社東芝 with 134 cases.
| Name | Cases |
|---|---|
| キヤノン株式会社 | 146 cases |
| 株式会社東芝 | 134 cases |
| トヨタ自動車株式会社 | 132 cases |
| 株式会社デンソー | 128 cases |
| TDK株式会社 | 96 cases |
| セイコーエプソン株式会社 | 47 cases |
| ソニーグループ株式会社 | 37 cases |
| シャープ株式会社 | 23 cases |
| 株式会社半導体エネルギー研究所 | 21 cases |
| 株式会社日立製作所 | 18 cases |
| パナソニックホールディングス株式会社 | 6 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as Parkinson病 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Among the top coapplicants, トヨタ自動車株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 11 cases, followed by 株式会社東芝 with 10 cases.
| Name | Cases |
|---|---|
| トヨタ自動車株式会社 | 11 cases |
| 株式会社東芝 | 10 cases |
| キヤノン株式会社 | 9 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Among the top coapplicants, キヤノン株式会社 has the highest number of joint applications in the last for the target period (2015 to 2025) with 146 cases, followed by 株式会社東芝 with 134 cases.
| Name | Cases |
|---|---|
| キヤノン株式会社 | 146 cases |
| 株式会社東芝 | 134 cases |
| トヨタ自動車株式会社 | 132 cases |
| ソニーグループ株式会社 | 37 cases |
| シャープ株式会社 | 23 cases |
| 株式会社日立製作所 | 18 cases |
| パナソニックホールディングス株式会社 | 6 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by Parkinson病’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by Parkinson病’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with 株式会社東芝
Parkinson病 filed 134 joint applications with 株式会社東芝 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 56 cases in total) is 9.3, and the median is 10.0. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2017 with 25 cases, and their lowest number in 2020 with 9 cases.
| Index | Value |
|---|---|
| Average | 9.3 patents |
| Std Dev | 4.5 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 10 cases | -28.57 % |
| 2022 year | 14 cases | +40.0 % |
| 2021 year | 10 cases | +11.11 % |
Trends in filing of joint patent applications with パナソニックホールディングス株式会社
Parkinson病 filed 6 joint applications with パナソニックホールディングス株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 3 cases in total) is 0.5, and the median is 0. The coefficient of variation (standard deviation/mean) is 1.5, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2016 with 2 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 0.5 patents |
| Std Dev | 0.8 |
| COV | 1.5 |
| Year | Cases | YOY |
|---|---|---|
| 2021 year | 2 cases | - |
| 2020 year | 0 cases | -100 % |
| 2019 year | 1 cases | - |
Trends in filing of joint patent applications with 株式会社日立製作所
Parkinson病 filed 18 joint applications with 株式会社日立製作所 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 9 cases in total) is 1.5, and the median is 2.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 4 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 1.5 patents |
| Std Dev | 1.1 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 2 cases | 0 |
| 2021 year | 2 cases | -33.3 % |
| 2020 year | 3 cases | +50.0 % |
Trends in filing of joint patent applications with ソニーグループ株式会社
Parkinson病 filed 37 joint applications with ソニーグループ株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 4 cases in total) is 0.7, and the median is 0. The coefficient of variation (standard deviation/mean) is 1.7, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 15 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 0.7 patents |
| Std Dev | 1.1 |
| COV | 1.7 |
| Year | Cases | YOY |
|---|---|---|
| 2020 year | 1 cases | -66.7 % |
| 2019 year | 3 cases | -62.5 % |
| 2018 year | 8 cases | +60.0 % |
Trends in filing of joint patent applications with キヤノン株式会社
Parkinson病 filed 146 joint applications with キヤノン株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 65 cases in total) is 10.8, and the median is 10.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2016 with 22 cases, and their lowest number in 2021 with 5 cases.
| Index | Value |
|---|---|
| Average | 10.8 patents |
| Std Dev | 7.0 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 8 cases | -55.6 % |
| 2022 year | 18 cases | +260 % |
| 2021 year | 5 cases | -76.2 % |
Information on important patents (JP)
The following shows JP patents held by Parkinson病 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and Parkinson病’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which Parkinson病 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 2 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許5474043 "（＋）−２−［１−（３−エトキシ−４−メトキシフェニル）−２−メチルスルホニルエチル］−４−アセチルアミノイソインドリン−１，３−ジオンを含む固形物形態、その組成物およびその使用" (Invalidation Trial day 2023-05-31) , next is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (Invalidation Trial day 2023-03-27) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許5474043 | （＋）−２−［１−（３−エトキシ−４−メトキシフェニル）−２−メチルスルホニルエチル］−４−アセチルアミノイソインドリン−１，３−ジオンを含む固形物形態、その組成物およびその使用 | 2023-05-31 |
| 2 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 5 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6335326 "コンジュゲート化莢膜糖類抗原を含む免疫原性組成物およびその使用" (1 times) , and the next most invalidation trial patent is 特許6554730 "ビフィドバクテリウム・ロンガム及び海馬ＢＤＮＦ発現" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6335326 | コンジュゲート化莢膜糖類抗原を含む免疫原性組成物およびその使用 | 1 times |
| 2 | 特許6554730 | ビフィドバクテリウム・ロンガム及び海馬ＢＤＮＦ発現 | 1 times |
| 3 | 特許6035372 | 肺癌治療剤 | 1 times |
| 4 | 特許6258428 | 肺癌治療剤 | 1 times |
| 5 | 特許6320582 | 半導体発光素子 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 16 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7381286 "深いＨＯＭＯ（最高被占分子軌道）発光体デバイス構造" (Opposition day 2024-05-15) , next is 特許7244922 "化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド" (Opposition day 2023-09-20) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7381286 | 深いＨＯＭＯ（最高被占分子軌道）発光体デバイス構造 | 2024-05-15 |
| 2 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-09-20 |
| 3 | 特許7210036 | アルツハイマー病および他の神経変性障害のためのバイオマーカーおよび診断方法 | 2023-07-20 |
| 4 | 特許7195995 | 排ガス浄化用触媒 | 2023-06-20 |
| 5 | 特許7245527 | 光電子素子 | 2023-05-22 |
| 6 | 特許7175477 | 金属部材 | 2023-05-09 |
| 7 | 特許7095774 | 撮像素子および撮像装置 | 2022-12-28 |
| 8 | 特許7086162 | ＡＳＣの前にＳＣＲ触媒を備えるシステム内でＤＯＣとして作用するＡＳＣを有する、ＤＯＣを伴わない排気システム | 2022-12-16 |
| 9 | 特許7074345 | 一本鎖ＲＮＡ編集オリゴヌクレオチド | 2022-11-18 |
| 10 | 特許7038664 | 操作された腫瘍溶解性ウイルス | 2022-09-15 |
Protested cases
List of latest Protested patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 61 patents Protest from third parties. The average number of Protest is 1.3 times. The most recently Protest patent is 特開2023-100665 "栄養製品" (Protest day 2024-12-13) , next is 特開2022-131316 "アルデヒドの製造装置およびアルデヒドの製造方法" (Protest day 2024-12-05) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2023-100665 | 栄養製品 | 2024-12-13 |
| 2 | 特開2022-131316 | アルデヒドの製造装置およびアルデヒドの製造方法 | 2024-12-05 |
| 3 | 特開2022-084400 | 導電性ペースト及び積層セラミックコンデンサ | 2024-11-14 |
| 4 | 特表2024-501951 | 小胞体ストレス減少用組成物 | 2024-11-05 |
| 5 | 特開2024-128965 | マンガン酸化物、マンガン酸化物粒子、近赤外線透過材料、及び近赤外線透過膜 | 2024-10-11 |
| 6 | 特開2022-050208 | 成形用組成物、成形体、およびガス発生抑制方法 | 2024-10-03 |
| 7 | 特表2024-504870 | 含窒素架橋複素環化合物、その調製方法及びその医薬的応用 | 2024-09-02 |
| 8 | 特開2022-132158 | 有機エレクトロルミネセンス材料及びデバイス | 2024-09-02 |
| 9 | 特開2024-025224 | チタン製釘およびチタン素材 | 2024-08-19 |
| 10 | 特許7586088 | 導電性組成物、導電性ペースト、電子部品、及び積層セラミックコンデンサ | 2024-07-13 |
| 11 | 特表2023-504011 | 金属－有機骨格押出物の製造方法 | 2024-06-18 |
| 12 | 特許7552231 | 導電性ペースト、電子部品、及び、積層セラミックコンデンサ | 2024-06-14 |
| 13 | 特表2023-523344 | パラセタモールの連続合成法 | 2024-03-21 |
| 14 | 特開2021-057342 | 固体イオン伝導体化合物、それを含む固体電解質、それを含む電気化学セル、及びその製造方法 | 2024-03-01 |
| 15 | 特許7617255 | 固体イオン伝導体化合物、それを含む固体電解質、それを含む電気化学セル、及びその製造方法 | 2024-03-01 |
| 16 | 特表2021-506842 | ポリペプチドの放射性標識 | 2024-01-31 |
| 17 | 特許7526482 | 成形用組成物及び成形体 | 2024-01-30 |
| 18 | 特許7559489 | 導電性ペースト、電子部品、及び、積層セラミックコンデンサ | 2024-01-10 |
| 19 | 特表2023-553379 | 核形成抑制被膜及び下地金属被膜を用いた導電性堆積層のパターニング | 2024-01-05 |
| 20 | 特許5368741 | 遷移金属酸化膜を有する半導体素子およびその製造方法 | 2024-01-05 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 124 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.2. The most protest patent is 特開2017-188482 "タッチスクリーンパネル用導電粒子、およびこれを含む導電材料" (4 times) , and the next most protest patent is 特許7058599 "中鎖トリグリセリド組成物" (4 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2017-188482 | タッチスクリーンパネル用導電粒子、およびこれを含む導電材料 | 4 times |
| 2 | 特許7058599 | 中鎖トリグリセリド組成物 | 4 times |
| 3 | 特許7385358 | チップ抵抗器 | 4 times |
| 4 | 特開2020-045332 | 慢性便秘症を治療するための医薬組成物 | 4 times |
| 5 | 特許6732749 | 水性ポリウレタン−ポリウレア分散体および該分散体を含有する水性ベースペイント | 3 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 285 patents Inspection from third parties. The average number of Inspection is 1.2 times. The most recently Inspection patent is 特開2022-084400 "導電性ペースト及び積層セラミックコンデンサ" (Inspection day 2024-12-19) , next is 特表2022-532564 "先駆制御性細胞栄養芽細胞およびその使用" (Inspection day 2024-12-10) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特開2022-084400 | 導電性ペースト及び積層セラミックコンデンサ | 2024-12-19 |
| 2 | 特表2022-532564 | 先駆制御性細胞栄養芽細胞およびその使用 | 2024-12-10 |
| 3 | 特表2021-519758 | ＬＦＡ３バリアントならびにその組成物および使用法 | 2024-12-06 |
| 4 | 特表2021-525549 | 腫瘍特異的ネオ抗原およびその使用方法 | 2024-12-04 |
| 5 | 特表2023-553379 | 核形成抑制被膜及び下地金属被膜を用いた導電性堆積層のパターニング | 2024-11-25 |
| 6 | 特表2022-516318 | カプセル化ポリヌクレオチド及び使用方法 | 2024-11-22 |
| 7 | 特表2024-501951 | 小胞体ストレス減少用組成物 | 2024-11-12 |
| 8 | 特表2024-512769 | 抗原特異的Ｔ細胞を生成し、疾患を治療するための材料及び方法 | 2024-11-06 |
| 9 | 特表2022-516574 | 新規ペプチドとその使用 | 2024-11-05 |
| 10 | 特表2021-511827 | ミトコンドリア機能を向上させる組成物および方法 | 2024-10-17 |
| 11 | 特開2024-128965 | マンガン酸化物、マンガン酸化物粒子、近赤外線透過材料、及び近赤外線透過膜 | 2024-10-16 |
| 12 | 特開2022-050208 | 成形用組成物、成形体、およびガス発生抑制方法 | 2024-10-15 |
| 13 | 特許6623353 | 抗ＰＤ−１抗体並びにその治療及び診断のための使用 | 2024-10-10 |
| 14 | 特許6742903 | プログラム死−１（ＰＤ−１）に対する抗体 | 2024-10-10 |
| 15 | 特表2022-536735 | エチレンジアミン四酢酸の作製 | 2024-10-09 |
| 16 | 特表2021-527707 | 亜鉛剤を使用した腫瘍学処置 | 2024-10-08 |
| 17 | 特表2022-512822 | 腫瘍を治療するための薬物の調製におけるファミチニブと組み合わせた抗ＰＤ－１抗体の使用 | 2024-10-08 |
| 18 | 特表2022-505022 | 腫瘍内アルファ放射体放射と細胞内病原体に対する細胞質プラズマセンサーの活性化 | 2024-09-26 |
| 19 | 特表2024-524458 | トランスグルタミナーゼの阻害剤 | 2024-09-19 |
| 20 | 特表2021-517895 | ＨＰＶ関連疾患を処置するための方法 | 2024-09-19 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 564 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.2. The most inspection patent is 特開2020-045332 "慢性便秘症を治療するための医薬組成物" (11 times) , and the next most inspection patent is 特開2016-155809 "狭窄病変および血栓溶解療法のための剪断による制御放出" (5 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2020-045332 | 慢性便秘症を治療するための医薬組成物 | 11 times |
| 2 | 特開2016-155809 | 狭窄病変および血栓溶解療法のための剪断による制御放出 | 5 times |
| 3 | 特許6298034 | 経皮吸収治療システム | 5 times |
| 4 | 特開2016-166173 | ＰＤ−１、Ｂ７−４の受容体、およびその使用 | 4 times |
| 5 | 特許7175068 | 癌治療に対する応答を予測するためのバイオマーカー | 4 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 3,765 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.7. The most cited patent is 特許6608753 "ＰｄＲｕ合金電極材料およびその製造方法" (336 times) , and the next most cited patent is 特許6089081 "磁気メモリ" (93 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6608753 | ＰｄＲｕ合金電極材料およびその製造方法 | 336 times |
| 2 | 特許6089081 | 磁気メモリ | 93 times |
| 3 | 特許6180697 | 排ガス浄化装置 | 76 times |
| 4 | 特許5985728 | 磁気メモリ | 40 times |
| 5 | 特許6778114 | イミド系タンパク質分解モジュレーター及び関連する使用方法 | 36 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.